Singapore markets close in 5 hours 17 minutes
Straits Times Index
3,268.23 +8.20 (+0.25%) Nikkei
26,720.06 +549.76 (+2.10%) Hang Seng
23,609.48 -197.52 (-0.83%) FTSE 100
7,554.31 +84.53 (+1.13%) BTC-USD
37,332.30 +1,272.62 (+3.53%) CMC Crypto 200
845.73 +26.22 (+3.20%)
VCPlus Limited (43E.SI)
SES - SES Delayed Price. Currency in SGD
Add to watchlist
As of 09:29AM SGT. Market open.
| Previous close | 0.0130 |
| Open | 0.0130 |
| Bid | 0.0130 x 0 |
| Ask | 0.0130 x 0 |
| Day's range | 0.0130 - 0.0130 |
| 52-week range | 0.0090 - 0.0360 |
| Volume | |
| Avg. volume | 8,034,781 |
| Market cap | 59.151M |
| Beta (5Y monthly) | 2.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0020 |
| Earnings date | 26 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it has submitted an application to the Japanese Ministry of Health, Labour and Welfare to manufacture and market darvadstrocel (development code: Cx601) for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease (CD).
© 2022 Yahoo. All rights reserved.
